| Serial Number | 86287682 |
| Word Mark | SAMIRNA |
| Filing Date | Wednesday, May 21, 2014 |
| Status | 704 - PARTIAL SECTION 8 ACCEPTED |
| Status Date | Wednesday, October 5, 2022 |
| Registration Number | 5052167 |
| Registration Date | Tuesday, October 4, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 19, 2016 |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Biological preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Medicated vaccines and serums for treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Capsules sold empty for pharmaceutical purposes for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Microspheres containing pharmaceutical preparations, for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Preparations and substances for facilitating delivery of pharmaceutical preparations, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Carriers for drug delivery, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Peptides for drug delivery, namely, drug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; Pharmaceutical preparations applied pharmaceutical drug delivery system, namely, elixirs for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies and a nanoparticle carrier for transferring siRNA in the cell or peptide; Chemical reagents for medical use; Pharmaceutical preparations for drug delivery into cells; Drug delivery formulations, namely, compositions consisting of nanoparticle for transferring siRNA in the cell or peptides; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purpose; Pharmaceutical preparations and substances for facilitating drug delivery in the form of nanoparticle for transferring siRNA in the cell or peptide for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing RNA for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing DNA for use in medical treatment via inhibition of gene expression |
| Goods and Services | Diagnostic preparations for research use; Reagents for scientific research use; Chemicals for laboratory analyses, other than for medical use, namely, chemicals for use in biotechnological product development; Chemicals for pharmaceutical purposes, namely, for use in the manufacture of drugs and medicines; Chemicals for the manufacture of medical products in the nature of pharmaceutical preparations; Biochemicals, namely, biochemical reagents used for non-medical purposes; Chemical preparations for the manufacture of medical products |
| Goods and Services | [ Drug delivery system; Implantable drug syringes for drug delivery devices; Implantable drug delivery pumps for drug delivery devices; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Injection device for pharmaceuticals; Microspheres, namely, unilaminar and bilaminar spherical particles comprising hydrophilic and hydrophobic polymers with diameters in the nanometer range used as a means for drug delivery for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies ] |
| Goods and Services | Pharmaceutical products research; Pharmaceutical products development; Research for medical products; Crude medicines research; Research and development of biotechnology for others; Quality control, namely, quality control of target gene expression activity with siRNA; Biotechnology research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 4, 2014 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 4, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, October 5, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 4, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIONEER CORPORATION |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34302 KR |
| Party Name | BIONEER CORPORATION |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon, 306-220 KR |
| Party Name | BIONEER CORPORATION |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon, 306-220 KR |
| Event Date | Event Description |
| Wednesday, October 5, 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Wednesday, October 5, 2022 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED |
| Tuesday, October 4, 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, April 26, 2022 | TEAS SECTION 8 RECEIVED |
| Monday, October 4, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, October 4, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 19, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 19, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 29, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 15, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, June 8, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 8, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 8, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 8, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 8, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, May 21, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 20, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 20, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 23, 2015 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, November 23, 2015 | PRIORITY ACTION E-MAILED |
| Monday, November 23, 2015 | PRIORITY ACTION WRITTEN |
| Monday, November 16, 2015 | DATA MODIFICATION COMPLETED |
| Monday, November 16, 2015 | ASSIGNED TO LIE |
| Monday, November 9, 2015 | ASSIGNED TO EXAMINER |
| Friday, October 23, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 23, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 23, 2015 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, August 21, 2015 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, August 21, 2015 | INQUIRY TO SUSPENSION E-MAILED |
| Friday, August 21, 2015 | SUSPENSION INQUIRY WRITTEN |
| Friday, February 6, 2015 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, February 6, 2015 | LETTER OF SUSPENSION E-MAILED |
| Friday, February 6, 2015 | SUSPENSION LETTER WRITTEN |
| Thursday, February 5, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 4, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 4, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 4, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 4, 2014 | NON-FINAL ACTION E-MAILED |
| Monday, August 4, 2014 | NON-FINAL ACTION WRITTEN |
| Monday, August 4, 2014 | ASSIGNED TO EXAMINER |
| Wednesday, June 4, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, May 24, 2014 | NEW APPLICATION ENTERED IN TRAM |